Skip to content
Medicines & Healthcare products Regulatory Agency
The National Institute for Biological Standards and Control

Confidence in biological medicines

  • Stay connected
  • Shopping Basket
  • Pay Now
  • Login / Register
  • Home
  • Products
  • Standardisation
  • Control testing
  • Science and research
  • Expert services
  • About us
  • QE2
  • Home  /  
  • Products  /  
  • Biological reference materials  /  
  • detail page

Bevacizumab (1st WHO International Standard) 18/210

Product description

Bevacizumab (1st WHO International Standard)

Product number

18/210

Category

  • Biotherapeutics
  • Monoclonal Antibodies

Keywords

Bioassay, VEGF165 neutralisation, VEGF165

Type of standard

International Standard

Instructions for Use

18-210.pdf Instructions for Use

Minimum quantity

1

Unit price

£140.00

Related products

Show more

Product number

02/286 Vascular Endothelial Growth Factor 165 (VEGF165)(recDNA, human sequence)(WHO Reference Reagent)

Type of standard

International Reference Reagent

Category

  • Biotherapeutics
  • Cytokines and Growth Factors
Product details
 

  • Current Influenza Standards

  • CJD Resource Centre

  • Result Reporting System (RRS)

  • Centre for AIDS Reagents

  • Ordering
  • Careers
  • Terms and conditions
  • Accessibility
  • Privacy notice
  • Cookies
  • Sitemap